choline alfoscerate / Generic mfg. - LARVOL DELTA

CHOLDEPS: Clinical Effectiveness of Choline Alphoscerate for Older Adults With Major Depression and Subjective Memory Complaints (clinicaltrials.gov) - P=N/A | N=120 | Completed | Sponsor: Samsung Medical Center | Not yet recruiting ➔ Completed | Trial completion date: Dec 2024 ➔ Jun 2026 | Trial primary completion date: Mar 2023 ➔ May 2026

Trial completion • Trial completion date • Trial primary completion date • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry

COALA: Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - P4 | N=630 | Recruiting | Sponsor: Daewoong Bio Inc.

New P4 trial • Alzheimer's Disease • CNS Disorders